This is Reshma Jagsi, M.D., D.Phil. Credit: University of Michigan Health System
The United States' global share of biomedical research spending fell from 51 percent in 2007 to 45 percent in 2012, while Japan and China saw dramatic increases in research spending.
The research and development spending in the United States dropped from $131 billion to $119 billion, when adjusted for inflation, from 2007-2012, while Japan increased spending by $9 billion and China increased by $6.4 billion. Overall, Asia's share of spending grew from 18 percent to 24 percent. Europe held steady at 29 percent.
Prior analyses have suggested the United States' share of global expenditures were once as high as 80 percent.
Results of this new analysis, conducted by researchers from industry and academia, including both medical researchers and economists, appear in the Jan. 2 New England Journal of Medicine.
"The United States has long been a world leader in driving research and development in the biomedical science. It's important to maintain that leadership role because biomedical research has a number of long term downstream economic benefits, especially around job creation," says study author Reshma Jagsi, M.D., D.Phil., associate professor of radiation oncology at the University of Michigan Health System.
Despite reductions in funding from the National Institutes of Health, including a 20 percent drop in purchasing power since 2003, the researchers discovered that the United States' decline was driven almost entirely by reduced investment from industry, not the public sector. This includes support for clinical trials testing potential new therapies.
Jagsi suggests that this may boil down to fewer regulations and less expense to conduct research in Asia – labor costs less, government may be offering subsidies and the research infrastructure is not as bureaucratic as it is in the United States.
"We were surprised the impact of industry funding was that dramatic, but it's key to note that government funding is equally important to maintain or grow. Research funded through the National Institutes of Health helps scientists understand how diseases work – this will happen slower as NIH funding continues to be cut," says study author Justin Chakma, a venture capital investor with Thomas, McNerney & Partners in La Jolla, Calif.
Historically, about half of drugs approved by the U.S. Food and Drug Administration had some federal government funding during the course of the research and development.
The authors note the critical need for increased NIH funding coupled with incentives to industry for investing in biomedical research and development here. They call the lack of a coordinated national biomedical R&D strategy "disappointing."
Explore further: New analysis shows that physician scientists are less likely to be engaged in biomedical research than in past
More information: New England Journal of Medicine, Vol. 370, No. 1, pp., Jan. 2, 2014
Medical Xpress on facebook
Related Stories
New analysis shows that physician scientists are less likely to be engaged in biomedical research than in past
Dec 12, 2013
A new analysis published in The FASEB Journal describes the declining participation of physician scientists in biomedical research. The article, "NIH research funding and early career physician scientists: continuing challe ...
Research funding slump alarms head of US cancer institutes
Sep 25, 2012
The head of the US National Cancer Institute warned Tuesday that the United States could lose its global leadership in research into the disease because of lower spending.
US risks losing out to Asia in medical research
Aug 23, 2012
Medical research saves lives, suffering and dollars – while also creating jobs and economic activity. The United States has long led the world, with hundreds of thousands of jobs and marketable discoveries generated by ...
CO2 emissions 'increased at slower rate in 2012'
Oct 31, 2013
The world's carbon dioxide (CO2) emissions increased at a slower rate in 2012—1.1 percent compared to a 2.9 percent annual increase over the past decade, a report said Thursday.
NIH official says spending cuts pose unprecedented threat to biomedical research
Oct 02, 2013
Scientific progress and innovation are speeding along, faster than ever before, but arbitrary spending cuts are posing an unprecedented threat.
Recommended for you
Researchers find new rhinovirus infection insights
Dec 31, 2013
(Medical Xpress)—On average, each of us catches a cold two to three times a year. However, how the common cold virus actually infects us is only partly understood. Researchers from the Max F. Perutz Laboratories ...
Vapor nanobubbles rapidly detect malaria through the skin
Dec 31, 2013
(Medical Xpress)—Rice University researchers have developed a noninvasive technology that accurately detects low levels of malaria infection through the skin in seconds with a laser scanner. The "vapor ...
Researchers investigate bone substitute from synthetic materials
Dec 31, 2013
When Lucia Téllez Jurado and her research team at the National Polytechnic Institute (IPN) were working in the synthesis of diverse materials, they realized that synthetically obtained hydroxylapatite, the ...
Nicotine exploits COPI to foster addiction
Dec 30, 2013
A study in The Journal of General Physiology helps explain how nicotine exploits the body's cellular machinery to promote addiction. The findings could lead to new therapies to help people quit smoking.
CALS researchers developing novel treatment for septic shock
Dec 27, 2013
(Medical Xpress)—By the time doctors diagnose septic shock, patients often are on a knife's edge. At that point, for every hour that treatment is delayed, a person's risk of death rises an alarming six percent.
Discovering a 'THRIL' that correlates with severity of Kawasaki disease
Dec 26, 2013
Sanford-Burnham Medical Research Institute scientists have discovered a new molecule that forms when certain white blood cells—macrophages—are stimulated in response to pathogens. The molecule, termed ...
User comments
© Medical Xpress 2011-2013, Science X network
This is Reshma Jagsi, M.D., D.Phil. Credit: University of Michigan Health System
The United States' global share of biomedical research spending fell from 51 percent in 2007 to 45 percent in 2012, while Japan and China saw dramatic increases in research spending.
The research and development spending in the United States dropped from $131 billion to $119 billion, when adjusted for inflation, from 2007-2012, while Japan increased spending by $9 billion and China increased by $6.4 billion. Overall, Asia's share of spending grew from 18 percent to 24 percent. Europe held steady at 29 percent.
Prior analyses have suggested the United States' share of global expenditures were once as high as 80 percent.
Results of this new analysis, conducted by researchers from industry and academia, including both medical researchers and economists, appear in the Jan. 2 New England Journal of Medicine.
"The United States has long been a world leader in driving research and development in the biomedical science. It's important to maintain that leadership role because biomedical research has a number of long term downstream economic benefits, especially around job creation," says study author Reshma Jagsi, M.D., D.Phil., associate professor of radiation oncology at the University of Michigan Health System.
Despite reductions in funding from the National Institutes of Health, including a 20 percent drop in purchasing power since 2003, the researchers discovered that the United States' decline was driven almost entirely by reduced investment from industry, not the public sector. This includes support for clinical trials testing potential new therapies.
Jagsi suggests that this may boil down to fewer regulations and less expense to conduct research in Asia – labor costs less, government may be offering subsidies and the research infrastructure is not as bureaucratic as it is in the United States.
"We were surprised the impact of industry funding was that dramatic, but it's key to note that government funding is equally important to maintain or grow. Research funded through the National Institutes of Health helps scientists understand how diseases work – this will happen slower as NIH funding continues to be cut," says study author Justin Chakma, a venture capital investor with Thomas, McNerney & Partners in La Jolla, Calif.
Historically, about half of drugs approved by the U.S. Food and Drug Administration had some federal government funding during the course of the research and development.
The authors note the critical need for increased NIH funding coupled with incentives to industry for investing in biomedical research and development here. They call the lack of a coordinated national biomedical R&D strategy "disappointing."
Explore further: New analysis shows that physician scientists are less likely to be engaged in biomedical research than in past
More information: New England Journal of Medicine, Vol. 370, No. 1, pp., Jan. 2, 2014
Medical Xpress on facebook
Related Stories
New analysis shows that physician scientists are less likely to be engaged in biomedical research than in past
Dec 12, 2013
A new analysis published in The FASEB Journal describes the declining participation of physician scientists in biomedical research. The article, "NIH research funding and early career physician scientists: continuing challe ...
Research funding slump alarms head of US cancer institutes
Sep 25, 2012
The head of the US National Cancer Institute warned Tuesday that the United States could lose its global leadership in research into the disease because of lower spending.
US risks losing out to Asia in medical research
Aug 23, 2012
Medical research saves lives, suffering and dollars – while also creating jobs and economic activity. The United States has long led the world, with hundreds of thousands of jobs and marketable discoveries generated by ...
CO2 emissions 'increased at slower rate in 2012'
Oct 31, 2013
The world's carbon dioxide (CO2) emissions increased at a slower rate in 2012—1.1 percent compared to a 2.9 percent annual increase over the past decade, a report said Thursday.
NIH official says spending cuts pose unprecedented threat to biomedical research
Oct 02, 2013
Scientific progress and innovation are speeding along, faster than ever before, but arbitrary spending cuts are posing an unprecedented threat.
Recommended for you
Researchers find new rhinovirus infection insights
Dec 31, 2013
(Medical Xpress)—On average, each of us catches a cold two to three times a year. However, how the common cold virus actually infects us is only partly understood. Researchers from the Max F. Perutz Laboratories ...
Vapor nanobubbles rapidly detect malaria through the skin
Dec 31, 2013
(Medical Xpress)—Rice University researchers have developed a noninvasive technology that accurately detects low levels of malaria infection through the skin in seconds with a laser scanner. The "vapor ...
Researchers investigate bone substitute from synthetic materials
Dec 31, 2013
When Lucia Téllez Jurado and her research team at the National Polytechnic Institute (IPN) were working in the synthesis of diverse materials, they realized that synthetically obtained hydroxylapatite, the ...
Nicotine exploits COPI to foster addiction
Dec 30, 2013
A study in The Journal of General Physiology helps explain how nicotine exploits the body's cellular machinery to promote addiction. The findings could lead to new therapies to help people quit smoking.
CALS researchers developing novel treatment for septic shock
Dec 27, 2013
(Medical Xpress)—By the time doctors diagnose septic shock, patients often are on a knife's edge. At that point, for every hour that treatment is delayed, a person's risk of death rises an alarming six percent.
Discovering a 'THRIL' that correlates with severity of Kawasaki disease
Dec 26, 2013
Sanford-Burnham Medical Research Institute scientists have discovered a new molecule that forms when certain white blood cells—macrophages—are stimulated in response to pathogens. The molecule, termed ...
User comments
© Medical Xpress 2011-2013, Science X network
0 comments:
Post a Comment